Product Program year 2025 Source: CMS Open Payments

Angiovac

Device Vit

PDI H965252810

Open in the dashboard

General payments

$1,240,999

4,118 payments

Research payments

$0

0 payments

Through program year 2025, $1,240,999 in general payments and $0 in research payments were reported against Angiovac (Vit).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $409,331 1,166
2024 General $230,005 965
2023 General $330,294 890
2022 General $271,368 1,097

Breakdown

Who paid General payments · program years 2022–2025
  1. AngioDynamics, Inc. $1,240,999 4,118 payments
Top recipients General payments · program year 2025
  1. Kenneth Rosenfield Cardiovascular Disease · Boston, MA $33,135 8% · 11 payments
  2. Sabah Butty Vascular & Interventional Radiology · Mishawaka, IN $20,319 5% · 13 payments
  3. V Reddy Thoracic Surgery (Cardiothoracic Vascular Surgery) · Nashville, TN $19,852 5% · 30 payments
  4. David Zlotnick Interventional Cardiology · Buffalo, NY $14,718 4% · 26 payments
  5. John Moriarty Vascular & Interventional Radiology · Los Angeles, CA $14,214 3% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Interventional Cardiology Internal Medicine $115,892 29% · 125 practitioners
  2. Vascular & Interventional Radiology Radiology $93,180 23% · 42 practitioners
  3. Thoracic Surgery (Cardiothoracic Vascular Surgery) $57,695 14% · 110 practitioners
  4. Cardiovascular Disease Internal Medicine $53,429 13% · 82 practitioners
  5. Vascular Surgery Surgery $45,806 11% · 31 practitioners

The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $56,613 14% · 66 recipients
  2. Florida $46,290 11% · 64 recipients
  3. Massachusetts $39,344 10% · 14 recipients
  4. New York $36,975 9% · 70 recipients
  5. Indiana $32,976 8% · 13 recipients

The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,118 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record